NOMD Stock Analysis: Nomad Foods | NYSE
Packaged Foods | NYSE, USA | Market Cap: 1.584m USD | 12M Return: -29.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.6M
EPS Trend: 33.4%
Qual. Beats: 1
Rev. Trend: -6.5%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Nomad Foods Limited is a UK-based frozen food manufacturer, marketer, and distributor operating across the United Kingdom and international markets. The companys product portfolio spans frozen fish (fish fingers, coated fish, natural fish), ready-to-cook vegetables, frozen poultry and meat products (nuggets, grills, burgers), ready-made meals (noodles, pasta, lasagna, pancakes), ice creams, and ancillary items such as soups, pizzas, bakery goods, and meat substitutes.
Products are distributed primarily to supermarkets and food retail chains under a portfolio of established brands, including Birds Eye, Green Cuisine, iglo, Findus, Aunt Bessies, Goodfellas, Frikom, Ledo, La Cocinera, and Belviva. Nomad Foods was founded in 2014 and is headquartered in Woking, United Kingdom.
As a packaged foods company in the consumer staples sector, Nomad Foods benefits from the typically recession-resistant demand profile of frozen convenience foods, which rely on extended shelf life and established cold-chain distribution. The companys brand-led, multi-category strategy-spanning fish, meat alternatives, and meals-reflects a common approach in the European packaged frozen food industry of leveraging heritage brands acquired through roll-up consolidation to achieve cross-market scale.
- European frozen food volumes drive organic revenue growth
- Fish and commodity input costs pressure gross margins
- Bolt-on acquisitions and deleveraging shape capital allocation
| Net Income: 133.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.21 > 1.0 |
| NWC/Revenue: 2.33% < 20% (prev 2.32%; Δ 0.01% < -1%) |
| CFO/TA 0.05 > 3% & CFO 308.6m > Net Income 133.4m |
| Net Debt (2.11b) to EBITDA (340.1m): 6.20 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.0m) vs 12m ago -8.27% < -2% |
| Gross Margin: 26.61% > 18% (prev 29.86%; Δ -3.25% > 0.5%) |
| Asset Turnover: 47.09% > 50% (prev 48.06%; Δ -0.97% > 0%) |
| Interest Coverage Ratio: 2.07 > 6 (EBIT TTM 230.0m / Interest Expense TTM 111.3m) |
| A: 0.01 (Total Current Assets 1.15b - Total Current Liabilities 1.08b) / Total Assets 6.34b |
| B: 0.20 (Retained Earnings 1.27b / Total Assets 6.34b) |
| C: 0.04 (EBIT TTM 230.0m / Avg Total Assets 6.37b) |
| D: 0.65 (Book Value of Equity 2.50b / Total Liabilities 3.84b) |
| Altman-Z'' = 1.65 = BB |
| DSRI: 1.03 (Receivables 423.4m/423.6m, Revenue 3.00b/3.08b) |
| GMI: 1.12 (GM 29.86% / 26.61%) |
| AQI: 1.01 (AQ_t 0.72 / AQ_t-1 0.72) |
| SGI: 0.98 (Revenue 3.00b / 3.08b) |
| TATA: -0.03 (NI 133.4m - CFO 308.6m) / TA 6.34b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of July 13, 2026, the stock is trading at USD 11.53 with a total of 650,283 shares traded. Over the past week, the price has changed by +0.96%, over one month by +10.55%, over three months by +21.41% and over the past year by -29.64%.
Current recommended Stop Loss: 11.10 (which is 3.7% or 1.3 ATR below the current price).
Nomad Foods has received a consensus analysts rating of 4.71. Therefore, it is recommended to buy NOMD.
- StrongBuy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.7 | 10.5% |
Market Cap EUR = 1.39b (1.58b USD * 0.8777 USD.EUR)
P/E Trailing = 11.0
P/E Forward = 9.3721
P/S = 0.5301
P/B = 0.5606
P/EG = 1.38
Revenue TTM = 3.00b EUR
EBIT TTM = 230.0m EUR
EBITDA TTM = 340.1m EUR
Long Term Debt = 2.27b EUR (from longTermDebt, last quarter)
Short Term Debt = 35.2m EUR (from shortTermDebt, last quarter)
Debt = 2.39b EUR (from shortLongTermDebtTotal, last quarter) + Leases 89.3m
Net Debt = 2.11b EUR (calculated: Debt 2.39b - CCE 282.5m)
Enterprise Value = 3.50b EUR (1.39b + Debt 2.39b - CCE 282.5m)
Interest Coverage Ratio = 2.07 (Ebit TTM 230.0m / Interest Expense TTM 111.3m)
EV/FCF = 15.38x (Enterprise Value 3.50b / FCF TTM 227.4m)
FCF Yield = 6.50% (FCF TTM 227.4m / Enterprise Value 3.50b)
FCF Margin = 7.58% (FCF TTM 227.4m / Revenue TTM 3.00b)
Net Margin = 4.45% (Net Income TTM 133.4m / Revenue TTM 3.00b)
Gross Margin = 26.61% ((Revenue TTM 3.00b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 25.67% (prev 25.57%)
Tobins Q-Ratio = 0.55 (Enterprise Value 3.50b / Total Assets 6.34b)
Interest Expense / Debt = 4.65% (Interest Expense 111.3m / Debt 2.39b)
Taxrate = 5.73% (8.11m / 141.5m)
NOPAT = 216.9m (EBIT 230.0m * (1 - 5.73%))
Current Ratio = 1.06 (Total Current Assets 1.15b / Total Current Liabilities 1.08b)
Debt / Equity = 0.96 (Debt 2.39b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = 6.20 (Net Debt 2.11b / EBITDA 340.1m)
Debt / FCF = 9.27 (Net Debt 2.11b / FCF TTM 227.4m)
Total Stockholder Equity = 2.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.09% (Net Income 133.4m / Total Assets 6.34b)
RoE = 5.28% (Net Income TTM 133.4m / Total Stockholder Equity 2.53b)
RoCE = 4.80% (EBIT 230.0m / Capital Employed (Equity 2.53b + L.T.Debt 2.27b))
RoIC = 4.22% (NOPAT 216.9m / Invested Capital 5.14b)
WACC = 4.92% (E(1.39b)/V(3.78b) * Re(5.84%) + D(2.39b)/V(3.78b) * Rd(4.65%) * (1-Tc(0.06)))
Discount Rate = 5.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.61 | Cagr: -6.30%
[DCF] Terminal Value 73.10% ; FCFF base≈259.2m ; Y1≈227.3m ; Y5≈183.6m
[DCF] Fair Price = 6.00 (EV 2.95b - Net Debt 2.11b = Equity 839.4m / Shares 139.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 33.40 | EPS CAGR: 1.84% | SUE: 2.37 | # QB: 1
Revenue Correlation: -6.46 | Revenue CAGR: -0.06% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.33 | Chg30d=+5.15% | Revisions=-50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.49 | Chg30d=-3.50% | Revisions=+57% | Analysts=4
EPS current Year (2026-12-31): EPS=1.49 | Chg30d=-0.53% | Revisions=+57% | GrowthEPS=-10.0% | GrowthRev=-3.4%
EPS next Year (2027-12-31): EPS=1.62 | Chg30d=-0.49% | Revisions=+62% | GrowthEPS=+8.5% | GrowthRev=+1.7%
[Analyst] Revisions Ratio: +53% (up=13, down=3)